Chemed EVP Westfall sells $4.2m in shares
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chemed Corp (CHE)
Chemed Corp stock price live, this page displays NYSE CHE stock exchange data. View the CHE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chemed Corp real time stock price chart below.
What Is the Chemed Corp Stock Price Today?
The Chemed Corp stock price today is 451.90.
What Is the Stock Symbol for Chemed Corp?
The stock symbol for Chemed Corp is ""CHE.""
What Stock Exchange Does Chemed Corp Trade On?
Chemed Corp is listed and trades on the NYSE stock exchange.
Is Chemed Corp a Good Stock to Buy?
Determining whether Chemed Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHE quote. (ISIN: US16359R1032)
What Is the Chemed Corp Stock Price Today?
The Chemed Corp stock price today is 451.90.
What Is the Stock Symbol for Chemed Corp?
The stock symbol for Chemed Corp is ""CHE.""
What Stock Exchange Does Chemed Corp Trade On?
Chemed Corp is listed and trades on the NYSE stock exchange.
Is Chemed Corp a Good Stock to Buy?
Determining whether Chemed Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHE quote. (ISIN: US16359R1032)
NYSE
Currency in USD
Fair Value
An estimate of a Chemed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
447.68
455.43
52 wk Range
408.42
623.61
CHE Scorecard
Full Analysis
Management has been aggressively buying back shares
CHE is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a Chemed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
447.68455.43
52 wk Range
408.42623.61
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CHE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Chemed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
567.25
Upside
+25.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 16 consecutive years
- Nicholas Westfall steps down as VITAS Healthcare CEO
- Investing.com
- Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Chemed EVP Westfall sells $4.2m in shares
- Investing.com
- Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - VITAS Healthcare names Joel Wherley as new CEO
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Chemed Corp Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Chemed Corp Earnings Call Summary for Q2/2025
- Q2 2025 EPS at $4.27, missing $5.39 forecast; revenue at $618.8M vs $650.6M expected; stock drops 8.8% after-hours
- Full-year EPS guidance revised down to $22.00-$22.30 from $24.95-$25.45; VITAS revenue up 5.8% YoY, Roto Rooter EBITDA down 18.7%
- CEO emphasizes focus on acquisitions and managing Medicare cap issues; CFO seeks 'right valuation' acquisitions
- Challenges: hospice market competition, digital ad changes affecting Roto Rooter, COVID-19 demographic shifts, private equity competition
- Company maintains strong financial health score of 3.05/5, with robust cash flows and conservative debt-to-equity ratio of 0.12
Last Updated: 30/07/2025, 18:08
Read Full TranscriptCompare CHE to Peers and Sector
Metrics to compare | CHE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCHEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.6x | 27.6x | −0.6x | |
PEG Ratio | −18.35 | 1.16 | 0.00 | |
Price/Book | 5.5x | 3.0x | 2.6x | |
Price / LTM Sales | 2.6x | 1.0x | 3.3x | |
Upside (Analyst Target) | 29.3% | 22.6% | 38.7% | |
Fair Value Upside | Unlock | 5.2% | 5.1% | Unlock |
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 567.25
(+25.53% Upside)
Earnings
Latest Release
Jul 29, 2025
EPS / Forecast
4.27 / 5.39
Revenue / Forecast
618.80M / 650.60M
People Also Watch
FAQ
What Stock Exchange Does Chemed Trade On?
Chemed is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Chemed?
The stock symbol for Chemed is "CHE."
What Is the Chemed Market Cap?
As of today, Chemed market cap is 6.57B.
What Is Chemed's Earnings Per Share (TTM)?
The Chemed EPS (TTM) is 19.65.
When Is the Next Chemed Earnings Date?
Chemed will release its next earnings report on 28 Oct 2025.
From a Technical Analysis Perspective, Is CHE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Chemed Stock Split?
Chemed has split 2 times.
How Many Employees Does Chemed Have?
Chemed has 15695 employees.
What is the current trading status of Chemed (CHE)?
As of 28 Aug 2025, Chemed (CHE) is trading at a price of 451.90, with a previous close of 455.33. The stock has fluctuated within a day range of 447.68 to 455.43, while its 52-week range spans from 408.42 to 623.61.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.